CellRapeutics™ Leukopak from Stroke Donor (XS-0426-XU290)

Name: CellRapeutics™ Leukopak from Stroke Donor
SKU: XS-0426-XU290
Rating: 5 (1 reviews)

Online Inquiry Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Collected from donors with a documented history of cerebrovascular accident, this Leukopak captures the systemic immune adaptations to neural tissue injury. The cellular profile reflects the acute-to-chronic transition of the neuro-inflammatory response, featuring markers of blood-brain barrier disruption and systemic leukocyte polarization. It is an ideal resource for researchers studying the immunological mechanisms of neuro-recovery and the risk of post-stroke secondary infections.

Specific Inquiry

Add to Cart

Donor Information

Product Name
CellRapeutics™ Leukopak from Stroke Donor

Cat. No.
XS-0426-XU290

Donor Age
Senior

Donor Health
Donors with a history of cerebrovascular accident. Leukocytes reflect the systemic immunological consequences of acute brain injury, showing markers of neuro-inflammatory signaling and long-term vascular immune remodeling.

Ethnicity
Diverse backgrounds available.

Anticoagulant
Acid Citrate Dextrose, formulated to stabilize the post-ischemic systemic immune response and maintain leukocyte metabolic health.

Additional Donor Information
Each lot features a Leukopak from donors who have experienced an ischemic or hemorrhagic stroke. Profiles include the timing of the event and neurological deficit scores, supporting research on systemic immune responses to CNS injury.

Clinical Profile
Stroke type, time since event, residual neurological deficits, and history of antiplatelet or anticoagulant therapy.

Additional Information

Medication History
Available upon request. Documentation of acute thrombolytic history, long-term antiplatelet/anticoagulant therapy, and medications for secondary prevention.

Formulation
Cryopreserved or Fresh options available.

Cell Purity
>90%

Cell Viability
>90%

Mycoplasma Testing
Negative

Sterility Testing
Negative

Genetic Stability Testing
The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.

Application
Drug Discovery, Immuno-oncology Research

Research Use Only
RUO

Quality Control
Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.

Storage
Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.

Shiping
Dry Ice

Handling Notes
Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.

Warnings
Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.

Size
Full Bag, Half Bag

Keywords
CellRapeutics™ Leukopak from Stroke Donor, Leukopak, Stroke

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Stroke Donor (XS-0426-XU290). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.